These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 2530097

  • 1. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M, Sjöholm B, Lappalainen J, Virtanen R.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):321-4. PubMed ID: 2530097
    [Abstract] [Full Text] [Related]

  • 2. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M, Lappalainen J, Hietala J, Sjöholm B.
    Psychopharmacology (Berl); 1990 Oct 10; 101(2):168-71. PubMed ID: 2140903
    [Abstract] [Full Text] [Related]

  • 3. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
    Lappalainen J, Hietala J, Koulu M, Sjöholm B, Syvälahti E.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Oct 10; 15(6):861-72. PubMed ID: 1722342
    [Abstract] [Full Text] [Related]

  • 4. 5-HT3 receptor antagonist ondansetron does not alter effects of amphetamine on DA metabolism.
    Koulu M, Lappalainen J, Hietala J, Sjöholm B, Virtanen R.
    Neuroreport; 1990 Oct 10; 1(2):126-8. PubMed ID: 2151795
    [Abstract] [Full Text] [Related]

  • 5. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
    Chen JP, van Praag HM, Gardner EL.
    Brain Res; 1991 Mar 15; 543(2):354-7. PubMed ID: 1711914
    [Abstract] [Full Text] [Related]

  • 6. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B, Domeney AM, Naylor RJ, Tyers MB.
    Br J Pharmacol; 1987 Dec 15; 92(4):881-94. PubMed ID: 2962686
    [Abstract] [Full Text] [Related]

  • 7. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
    Lategan AJ, Marien MR, Colpaert FC.
    Life Sci; 1992 Dec 15; 50(14):995-9. PubMed ID: 1372673
    [Abstract] [Full Text] [Related]

  • 8. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA, Piercey MF.
    J Neural Transm (Vienna); 1998 Dec 15; 105(6-7):749-67. PubMed ID: 9826116
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E, Durst R, Frucht Y, Globus M.
    Eur J Pharmacol; 1983 May 06; 89(3-4):279-82. PubMed ID: 6873163
    [Abstract] [Full Text] [Related]

  • 10. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB, Wyder KJ, Jakubovic A, Fibiger HC.
    Br J Pharmacol; 1990 Mar 06; 99(3):509-15. PubMed ID: 2110017
    [Abstract] [Full Text] [Related]

  • 11. Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.
    Waldmeier PC.
    Experientia; 1980 Sep 15; 36(9):1092-4. PubMed ID: 6448165
    [Abstract] [Full Text] [Related]

  • 12. Repeated exposure to the abused inhalant toluene alters levels of neurotransmitters and generates peroxynitrite in nigrostriatal and mesolimbic nuclei in rat.
    Riegel AC, Ali SF, Torinese S, French ED.
    Ann N Y Acad Sci; 2004 Oct 15; 1025():543-51. PubMed ID: 15542760
    [Abstract] [Full Text] [Related]

  • 13. Effects of baclofen on striatal 5-HT mediated by the nigrostriatal dopamine system.
    Waldmeier PC, Feldtrauer JJ, Kam R, Stöcklin K.
    Eur J Pharmacol; 1979 Mar 01; 54(3):279-87. PubMed ID: 428427
    [Abstract] [Full Text] [Related]

  • 14. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
    Csernansky JG, Barnes DE, Bellows EP, Lombrozo L.
    Life Sci; 1990 Mar 01; 46(10):707-13. PubMed ID: 2314192
    [Abstract] [Full Text] [Related]

  • 15. Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors.
    De Deurwaerdère P, Stinus L, Spampinato U.
    J Neurosci; 1998 Aug 15; 18(16):6528-38. PubMed ID: 9698340
    [Abstract] [Full Text] [Related]

  • 16. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H, Engberg G, Pileblad E.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul 15; 344(1):16-28. PubMed ID: 1663587
    [Abstract] [Full Text] [Related]

  • 17. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
    Deutch AY, Tam SY, Freeman AS, Bowers MB, Roth RH.
    Eur J Pharmacol; 1987 Feb 24; 134(3):257-64. PubMed ID: 3569414
    [Abstract] [Full Text] [Related]

  • 18. Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function.
    Lucas G, Di Matteo V, De Deurwaerdère P, Porras G, Martín-Ruiz R, Artigas F, Esposito E, Spampinato U.
    Eur J Neurosci; 2001 Mar 24; 13(5):889-98. PubMed ID: 11264661
    [Abstract] [Full Text] [Related]

  • 19. Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
    Teicher MH, Barber NI, Gelbard HA, Gallitano AL, Campbell A, Marsh E, Baldessarini RJ.
    Neuropsychopharmacology; 1993 Sep 24; 9(2):147-56. PubMed ID: 8216697
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of gonadal steroids on dopamine metabolism in mesolimbic and nigro-striatal pathways of male rat brain.
    Alderson LM, Baum MJ.
    Brain Res; 1981 Aug 10; 218(1-2):189-206. PubMed ID: 7272735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.